These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37181111)

  • 1. Enzyme replacement therapy in lysosomal acid lipase deficiency (LAL-D): a systematic literature review.
    Bashir A; Tiwari P; Duseja A
    Ther Adv Rare Dis; 2021; 2():26330040211026928. PubMed ID: 37181111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies.
    Vijay S; Brassier A; Ghosh A; Fecarotta S; Abel F; Marulkar S; Jones SA
    Orphanet J Rare Dis; 2021 Jan; 16(1):13. PubMed ID: 33407676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: Final results of the ARISE study.
    Burton BK; Feillet F; Furuya KN; Marulkar S; Balwani M
    J Hepatol; 2022 Mar; 76(3):577-587. PubMed ID: 34774639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency.
    Valayannopoulos V; Malinova V; Honzík T; Balwani M; Breen C; Deegan PB; Enns GM; Jones SA; Kane JP; Stock EO; Tripuraneni R; Eckert S; Schneider E; Hamilton G; Middleton MS; Sirlin C; Kessler B; Bourdon C; Boyadjiev SA; Sharma R; Twelves C; Whitley CB; Quinn AG
    J Hepatol; 2014 Nov; 61(5):1135-42. PubMed ID: 24993530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease.
    Balwani M; Breen C; Enns GM; Deegan PB; Honzík T; Jones S; Kane JP; Malinova V; Sharma R; Stock EO; Valayannopoulos V; Wraith JE; Burg J; Eckert S; Schneider E; Quinn AG
    Hepatology; 2013 Sep; 58(3):950-7. PubMed ID: 23348766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sebelipase alfa for lysosomal acid lipase deficiency: 5-year treatment experience from a phase 2 open-label extension study.
    Malinová V; Balwani M; Sharma R; Arnoux JB; Kane J; Whitley CB; Marulkar S; Abel F
    Liver Int; 2020 Sep; 40(9):2203-2214. PubMed ID: 32657505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of a patient with lysosomal acid lipase deficiency and first results after initiation of treatment with Sebelipase alfa: A case report.
    Soll D; Spira D; Hollstein T; Haberbosch L; Demuth I; Steinhagen-Thiessen E; Bobbert T; Spranger J; Kassner U
    Mol Genet Metab Rep; 2019 Sep; 20():100479. PubMed ID: 31249784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.
    Thelwall PE; Smith FE; Leavitt MC; Canty D; Hu W; Hollingsworth KG; Thoma C; Trenell MI; Taylor R; Rutkowski JV; Blamire AM; Quinn AG
    J Hepatol; 2013 Sep; 59(3):543-9. PubMed ID: 23624251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sebelipase Alfa: A Review in Lysosomal Acid Lipase Deficiency.
    Frampton JE
    Am J Cardiovasc Drugs; 2016 Dec; 16(6):461-468. PubMed ID: 27878737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency.
    Wilson DP; Friedman M; Marulkar S; Hamby T; Bruckert E
    J Clin Lipidol; 2018; 12(3):604-614. PubMed ID: 29628368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.
    Maciejko JJ
    Am J Cardiovasc Drugs; 2017 Jun; 17(3):217-231. PubMed ID: 28197978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa.
    Su K; Donaldson E; Sharma R
    Appl Clin Genet; 2016; 9():157-167. PubMed ID: 27799810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD.
    Carter A; Brackley SM; Gao J; Mann JP
    J Hepatol; 2019 Jan; 70(1):142-150. PubMed ID: 30315827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lysosomal acid lipase deficiency (LAL-D) : Diagnostic and therapeutic options in an underdiagnosed disease].
    Synoracki S; Kathemann S; Schmid KW; Jastrow H; Baba HA
    Pathologe; 2018 May; 39(3):249-254. PubMed ID: 29234937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.
    Jones SA; Rojas-Caro S; Quinn AG; Friedman M; Marulkar S; Ezgu F; Zaki O; Gargus JJ; Hughes J; Plantaz D; Vara R; Eckert S; Arnoux JB; Brassier A; Le Quan Sang KH; Valayannopoulos V
    Orphanet J Rare Dis; 2017 Feb; 12(1):25. PubMed ID: 28179030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal acid lipase deficiency allograft recurrence and liver failure- clinical outcomes of 18 liver transplantation patients.
    Bernstein DL; Lobritto S; Iuga A; Remotti H; Schiano T; Fiel MI; Balwani M
    Mol Genet Metab; 2018 May; 124(1):11-19. PubMed ID: 29655841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sebelipase alfa: first global approval.
    Shirley M
    Drugs; 2015 Nov; 75(16):1935-40. PubMed ID: 26452566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disturbance of lipid homeostasis in lysosomal lipase deficiency – pathomechanism, diagnosis and treatment].
    Lipiński P; Tylki-Szymańska A
    Postepy Biochem; 2021 Sep; 67(3):231-235. PubMed ID: 34894393
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.